Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT06489860
Brief Summary:
SARS-CoV-2 produced strong pluripotent stem cells and brain cells to protect Telomere chromosomes to maintain Acid Deoxyribonucleic (ADN) Molecules.
Detailed Description:
SARS-CoV-2 produced strong pluripotent stem cells and brain cells to change and disappear defective cells in virus variants, Covid-19 disease. Pluripotent stem cells produced strong cells serve as a repair system, replacing damaged cells, defective cells and dead cells.
CHEMISTRY:
SARS-CoV-2 does not use any chemicals, no colors and no additives and no preservatives.
Toxicology:
SARS-CoV-2 product is not adverse effect, non-toxic and no pharmacal toxicology.
SARS-CoV-2 is not placebo drug
Study:
NCT06489860
Study Brief:
Protocol Section:
NCT06489860